Anavex Life Sciences Corporation, No. 1:24-cv-01910 (S.D.N.Y.), the Anavex class action lawsuit charges Anavex and an Anavex executive with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the Anavex class action lawsuit, please provide your information here: https://www.rgrdlaw.com/cases-anavex-life-sciences-corporation-class-action-lawsuit-avxl.html You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at. Lead plaintiff motions for the Anavex class action lawsuit must be filed with the court no later than May 13, 2024. CASE ALLEGATIONS : Anavex investigates, manufactures, and markets pharmaceuticals for central nervous system ("CNS") disorders.